TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ZBIO

Zenas BioPharma, Inc.

Healthcare · Biotechnology

27.50$ -7.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZBIO
Line item 2022 2023 2024 2025
– -61.1% -2,393.5% -1,723.3%
– 0.2% 2.7% -18.8%
– 7.0% 216.4% 263.5%
– -16.1% 508.6% 9.5%
– 0.0% 2.6% 0.2%
– 0.0% -611.0% -2,518.9%
– – – 2.8%
– 40.0% 0.0% –
– 40.2% 8,259.2% 2,152.8%
– -20.7% 5,257.8% -2,091.9%
– -61.1% -2,396.1% -1,723.5%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?